Open Prostate Clinical Trials

Prostate Studies Currently Recruiting Participants at the Simmons Cancer Research Center at Southern Illinois University School of Medicine

Protocol Title	Study #	Study Group
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial	RTOG 0924	RTOG
A Randomized, Phase III Study of Standard Dosing Versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer	CTSU/CALGB 70604	CICCOP
Phase II, Randomized Study of MK-2206 - Bicalutamide Combination in Patients With Rising PSA at High-Risk of Progression After Primary Therapy	ECOG 2809	CICCOP
A randomized discontinuation phase 2 study of AZD0530 as a metastasis inhibitor in castrate resistant prostate cancer	SCI 11-037	SCI
A Randomized Phase II Dose Finding Study of ArginMax for Its Effect on Erectile Function and Quality of Life in Survivors of Prostate Cancer Previously Treated With Radiotherapy	CCCWFU 98110	CICCOP
A Randomized Phase II Study of Combined Androgen Deprivation Versus Combined Androgen Deprivation With IMC-A12 for Patients With New Hormone-Sensitive Metastatic Prostate Cancer	SWOG S0925	CICCOP
A Prospective Phase II Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy	RTOG 0526	RTOG
A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer	RTOG 0815	RTOG
A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate Risk Prostatic Carcinoma	RTOG 0232	RTOG
A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPORT) In Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy	RTOG 0534	RTOG
CHAARTED: ChemoHormonal Therapy Versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer [CHAARTED]	ECOG E3805	CICCOP
A Randomized, Double-blind, Placebo-controlled Phase III Trial to Evaluate the Effectiveness of a Phosphodiesterase 5 Inhibitor, Tadalafil, in Prevention of Erectile Dysfunction in Patients Treated With Radiotherapy for Prostate Cancer	RTOG 0831	RTOG
A Randomized Phase II Dose Finding Study of ArginMax for Its Effect on Erectile Function and Quality of Life in Survivors of Prostate Cancer Previously Treated With Radiotherapy	CCCWFU 98110	CICCOP

Although our objective is to provide an updated listing of available clinical trials please note that a listing here does not guarantee that a trial is open or available to any specific patient and that there may be additional trials available that are not listed. Complete information is only available from a treating physician.

Contact Information:

Simmons Cancer Institute Clinical Trials Office
Mail Code 9677 Fax (217) 545-6823

Kathy Robinson, PhD,
Director of Clinical Trials
(217) 545-1946
: Allicent Curry, RN,BSN, OCN
Research Nurse
(217) 545-7929

SIU COG

Carol Peterson, RN, CCRP (217) 545-7377

SIU IM

Amanda Fogleman, B.S. (217) 545-0592

Krista Whitlock (217) 545-7750

SIU Thoracic

Theresa Boley, RN, MSN, APN/FNP-BC, CCRP (217) 545-5000
: Cathy Leslie, RN, CCRP (217) 545-8184; Mary Ray, MS (217) 545-7420

RTOG: Radiation Therapy Oncology Group:

Diana Weyhenmeyer, RN, MA, OCN (217) 544-6464 ext. 45591

CICCOP: Central Illinois Community Clinical Oncology Program
Memorial Medical Center CICCOP Research Contacts:

Treatment/Cancer Control:

Holly Thomas (217) 788-4178

Stephanie Allbritton (217) 788-3544

Brooke Trickey (217) 217-788-3560

Karen Graber (217) 588-2961

Chrissy Tucker (217) 788-4444
Sunny Hampsey (217) 788-4233

Back to Open Clinical Trials